Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001193125-25-236739·Alto Neuroscience, Inc.
Schedule 13G ownership disclosure
Alto Neuroscience Inc
Common Stock, $0.0001 par value per share · CUSIP: 02157Q109
Event date: 2025-10-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLC
Shares: 1,989,393 · Class: 7.3%
- Joseph Edelman
Shares: 1,989,393 · Class: 7.3%
- Perceptive Life Sciences Master Fund, Ltd.
Shares: 1,989,393 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-236739
- Form type
- SCHEDULE 13G
- Filer
- Alto Neuroscience, Inc.
- CIK
- CIK 1999480
- Filed
- Oct 10, 2025
- Reporting period
- Oct 03, 2025
- Description
- Schedule 13G beneficial ownership